These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6655822)

  • 21. [Combined action of cephamycin and aminoglycoside antibiotics].
    Tanaka M; Kawabata S; Nishino T; Tanino T
    Jpn J Antibiot; 1983 Oct; 36(10):2869-80. PubMed ID: 6674522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical experience with cefoxitin in the surgical field].
    Hirano Y; Watanabe T; Matsumoto S; Nishida S; Fukamachi S; Take T; Okuma Y; Morita K; Furusho Y; Ishikawa S
    Jpn J Antibiot; 1984 Jan; 37(1):104-10. PubMed ID: 6727031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical findings of cefoxitin in the treatment of obstetric and gynecological infections (author's transl)].
    Hayasaki M; Iwasa SU; Noda K; Yamada Y; Ito K; Iida M; Chin C
    Jpn J Antibiot; 1982 Jan; 35(1):189-201. PubMed ID: 7069930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical studies on cefoxitin in the field of obstetrics and gynecology].
    Cho N; Suzuki H; Itagaki T; Hirai N; Seki M; Kondo H; Nishimoto S; Togo M; Simizu S; Ozaki T
    Jpn J Antibiot; 1985 Feb; 38(2):212-22. PubMed ID: 4009945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of cefoxitin on infections secondary to hematopoietic malignancies].
    Sawada H; Ishikura H; Izumi Y; Usui T; Konishi H; Uchino H
    Jpn J Antibiot; 1982 Jun; 35(6):1610-4. PubMed ID: 7131771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical studies on cefoxitin in the treatment of respiratory tract infections].
    Kuwabara M; Kodomari Y; Jyo T; Kuraoka T; Mitsuyama T; Kodomari N; Iwamoto K; Miyazawa T; Watanabe T; Morikawa E
    Jpn J Antibiot; 1984 Sep; 37(9):1685-93. PubMed ID: 6512985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical studies of cefoxitin for the treatment of respiratory tract infections (author's transl)].
    Suetsugu S; Naito T; Ishikawa H; Umeda H; Suzuki K; Morise M; Sakai S; Shimokata K; Katayama T; Kobayashi T; Tsunekawa H; Nishimura M; Iwakura M; Nishiwaki K; Nomura Y; Yoshikawa K; Fujii K; Izumi S; Katoh T; Ito T; Hattori J; Yoshii S; Takeura S; Maeda F
    Jpn J Antibiot; 1982 Feb; 35(2):375-93. PubMed ID: 7087175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Laboratory and clinical studies on cefoxitin in pediatric field (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Osuga T; Inokuma K
    Jpn J Antibiot; 1981 Mar; 34(3):287-304. PubMed ID: 7289022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical studies of cefoxitin in the pediatric field (author's transl)].
    Kida K; Watanabe N; Matsuda H; Murase M
    Jpn J Antibiot; 1981 Mar; 34(3):367-73. PubMed ID: 7289029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical experience with cefoxitin in pediatric field (author's transl)].
    Okamoto T; Ohara K; Tomimatsu H; Hosoda T
    Jpn J Antibiot; 1981 Mar; 34(3):352-8. PubMed ID: 7289027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical studies of cefoxitin in the field of internal medicine].
    Ito A; Shindo K; Sakamoto H; Sano F; Ishigatsubo Y; Matsumura M; Tani K; Maruta I; Kodama F; Fukushima K
    Jpn J Antibiot; 1983 Jan; 36(1):84-92. PubMed ID: 6842829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical experience with cefoxitin in bacterial infections of children (author's transl)].
    Yuasa Y; Ichioka T; Sekiguchi T; Miyao M; Toi C; Hayashi K; Yamashita K; Tanaka H
    Jpn J Antibiot; 1981 Mar; 34(3):359-66. PubMed ID: 7289028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of therapy with cefoxitin.
    McCloskey RV; Goren RC
    Clin Ther; 1980; 3(2):66-79. PubMed ID: 7448845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibacterial activity of cefoperazone against anaerobic bacteria (author's transl)].
    Imamura H; Kobayashi T; Murata K; Kohbata S; Watanabe I; Marui T; Watanabe K; Ninomiya K; Ueno K; Suzuki S
    Jpn J Antibiot; 1980 Nov; 33(11):1171-82. PubMed ID: 6454011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical studies of cefoxitin with special reference to pulmonary suppuration and pyothorax with respiratory tract infection].
    Ito T
    Jpn J Antibiot; 1984 Sep; 37(9):1679-84. PubMed ID: 6512984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical trial of cefoxitin used in the treatment of patients with cholesteatoma undergoing surgical procedures].
    Morikawa K
    Jpn J Antibiot; 1982 Dec; 35(12):2761-7. PubMed ID: 7182531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefoxitin: clinical evaluation in thirty-eight patients.
    Heseltine PN; Busch DF; Meyer RD; Finegold SM
    Antimicrob Agents Chemother; 1977 Mar; 11(3):427-34. PubMed ID: 855997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of cefoxitin for surgical infections. Especially, the effect for resisted cases to therapy with another cephalosporins (author's transl)].
    Sakata I
    Jpn J Antibiot; 1981 Jul; 34(7):1044-7. PubMed ID: 7321180
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experience with cefoxitin used for the prevention of postoperative infections].
    Kato F; Miyazaki T; Itoh K; Okamura H; Tohga S
    Jpn J Antibiot; 1982 Aug; 35(8):1993-7. PubMed ID: 7154247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.